RXRA and fatty liver disease: We addressed the potential inhibitory effect of miR6262 on RXRA gene expression and evaluated the impact of miR6262 on key metabolic genes in hepatocytes (HepG2) untreated and exposed to free fatty acids (FFA) to mimic hepatic steatosis, and in brite adipocytes (hMADS cells).